What is GLPGF stock price today?

GLPGF (Galapagos NV) stock is trading at $28.08 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is GLPGF stock going up or down today?

GLPGF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GLPGF stock now?

The decision to buy GLPGF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GLPGF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GLPGF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GLPGF stock overvalued or undervalued?

GLPGF currently trades at a P/E ratio of 5.66, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if GLPGF is fairly priced.

What is GLPGF's P/E ratio?

GLPGF has a price-to-earnings (P/E) ratio of 5.66, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GLPGF's market cap?

GLPGF (Galapagos NV) has a market capitalization of $3.21 billion, making it a small-cap stock.

What is GLPGF's price to book ratio?

GLPGF trades at a price-to-book (P/B) ratio of 0.49, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does GLPGF pay dividends?

GLPGF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GLPGF's dividend yield?

GLPGF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GLPGF stock a good long-term investment?

GLPGF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GLPGF's revenue growth rate?

GLPGF has shown revenue growth of -0.9% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, GLPGF is profitable with a profit margin of 0.5%. This indicates the company generates 0.5 cents of profit for every dollar of revenue.

What are the risks of investing in GLPGF?

Key risks for GLPGF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GLPGF compare to its competitors?

Compare GLPGF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GLPGF's performance and positioning.

What is GLPGF's stock price target for 2026?

Our AI model provides price targets for GLPGF based on fundamental analysis: Bull case $36.50 (+30%), Base case $32.29 (+15%), Bear case $25.27 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about GLPGF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GLPGF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GLPGF's next earnings report?

GLPGF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GLPGF - Galapagos NV

NYSE * Healthcare * Biotechnology

$28.08

+$0.00 (+0.00%)

About Galapagos NV

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

GLPGF Key Statistics

Market Cap

$3.21B

P/E Ratio

5.66

P/B Ratio

0.49

EPS

$8.61

Revenue Growth

-0.9%

Profit Margin

0.5%

Employees

704

How GLPGF Compares to Peers

GLPGF has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

GLPGF has the highest profit margins in Biotechnology

GLPGF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GLPGF(This stock)	$3.21B	5.7	-1%	0.5%	-
AMGNAmgen Inc	$186.52B	24.0	0%	0.2%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.12B	26.2	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$64.89B	15.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$29.00B	21.1	0%	0.1%	vs BIIB

Galapagos NV Company Information

Headquarters: SchaliEnhoevedreef 20 T, Mechelen, Belgium, 2800, undefined
Website: lakefrontbio.com
Sector: Healthcare
Industry: Biotechnology

About Galapagos NV

GLPGF Key Statistics

How GLPGF Compares to Peers

Galapagos NV Company Information

Upcoming Events for GLPGF